Search Results

Displaying Results 76-100 of 125 "'IDR'"

Oct 14, 2025, 16:14 ET Nutex Health Inc. (NUTX) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit

(2) as a result, to the extent that they were the product of fraudulent conduct, revenues attributable to the Company's engagement with HaloMD in the IDR process were unsustainable; (3) in addition, the Company overstated the extent to which it had remediated, and/or its ability to remediate, the material

More news about: Law Offices of Howard G. Smith


Oct 14, 2025, 07:30 ET Soligenix Updates United States Medical Advisory Board for Cutaneous T-Cell Lymphoma

programs in this business segment also include expansion of synthetic hypericin (SGX302) into psoriasis, our first-in-class innate defense regulator (IDR) technology, dusquetide (SGX942) for the treatment of inflammatory diseases, including oral mucositis in head and neck cancer, and (SGX945) in Behçet's

More news about: Soligenix


Oct 14, 2025, 02:57 ET NUTX Deadline: NUTX Investors Have Opportunity to Lead Nutex Health Inc. Securities Fraud Lawsuit

resolution vendor ("IDR"), was achieving lucrative arbitration results for Nutex by engaging in a coordinated scheme to defraud insurance companies; (2) as a result, to the extent that they were the product of fraudulent conduct, revenues attributable to Nutex's engagement with HaloMD in the IDR process were

More news about: THE ROSEN LAW FIRM, P. A.


Oct 13, 2025, 14:34 ET Pomerantz Law Firm Announces the Filing of a Class Action Against Nutex Health Inc. and Certain Officers - NUTX

appeals using the IDR process."  In response, in July 2024, the Company engaged with HaloMD, a "third-party IDR vendor," to "assist in the recovery of certain out of network claims" in the IDR process. While Nutex did not disclose the identity of its third-party IDR vendor to investors

More news about: Pomerantz LLP


Oct 13, 2025, 09:00 ET The Gross Law Firm Announces the Filing of a Securities Class Action on Behalf of Nutex Health Inc.(NUTX) Shareholders

third-party IDR vendor, was achieving lucrative arbitration results for Nutex by engaging in a coordinated scheme to defraud insurance companies; (ii) as a result, to the extent that they were the product of fraudulent conduct, revenues attributable to the Company's engagement with HaloMD in the IDR process

More news about: Gross Law Firm


Oct 10, 2025, 20:33 ET SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Nutex Health

(2) as a result, to the extent that they were the product of fraudulent conduct, revenues attributable to the Company's engagement with HaloMD in the IDR process were unsustainable; (3) in addition, the Company overstated the extent to which it had remediated, and/or its ability to remediate, the material

More news about: Faruqi & Faruqi, LLP


Oct 10, 2025, 09:10 ET Mining Stocks Positioned for Profit Explosion as Gold Bullion Tops $4,000

(TSX: KNT) (OTCQX: KNTNF), and Idaho Strategic Resources, Inc. (NYSE-American: IDR).

More news about: USA News Group


Oct 10, 2025, 09:00 ET Nutex Health Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - NUTX

third-party IDR vendor, was achieving lucrative arbitration results for Nutex by engaging in a coordinated scheme to defraud insurance companies; (ii) as a result, to the extent that they were the product of fraudulent conduct, revenues attributable to the Company's engagement with HaloMD in the IDR process

More news about: Levi & Korsinsky, LLP


Oct 09, 2025, 08:45 ET Nutex Health Inc. Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm for More Information - NUTX

third-party IDR vendor, was achieving lucrative arbitration results for Nutex by engaging in a coordinated scheme to defraud insurance companies; (ii) as a result, to the extent that they were the product of fraudulent conduct, revenues attributable to the Company's engagement with HaloMD in the IDR process

More news about: The Gross Law Firm


Oct 08, 2025, 23:40 ET NUTX Deadline: NUTX Investors Have Opportunity to Lead Nutex Health Inc. Securities Fraud Lawsuit

resolution vendor ("IDR"), was achieving lucrative arbitration results for Nutex by engaging in a coordinated scheme to defraud insurance companies; (2) as a result, to the extent that they were the product of fraudulent conduct, revenues attributable to Nutex's engagement with HaloMD in the IDR process were

More news about: THE ROSEN LAW FIRM, P. A.


Oct 08, 2025, 16:30 ET Pomerantz Law Firm Announces the Filing of a Class Action Against Nutex Health Inc. and Certain Officers - NUTX

appeals using the IDR process."  In response, in July 2024, the Company engaged with HaloMD, a "third-party IDR vendor," to "assist in the recovery of certain out of network claims" in the IDR process.  While Nutex did not disclose the identity of its third-party IDR vendor to investors

More news about: Pomerantz LLP


Oct 07, 2025, 16:05 ET Nutex Health Inc. (NUTX) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit

(2) as a result, to the extent that they were the product of fraudulent conduct, revenues attributable to the Company's engagement with HaloMD in the IDR process were unsustainable; (3) in addition, the Company overstated the extent to which it had remediated, and/or its ability to remediate, the material

More news about: Glancy Prongay & Murray LLP


Oct 07, 2025, 07:30 ET Soligenix Achieves Important Safety Milestone in its Confirmatory Phase 3 Clinical Trial of HyBryte™ for the Treatment of Cutaneous T-Cell Lymphoma

programs in this business segment also include expansion of synthetic hypericin (SGX302) into psoriasis, our first-in-class innate defense regulator (IDR) technology, dusquetide (SGX942) for the treatment of inflammatory diseases, including oral mucositis in head and neck cancer, and (SGX945) in Behçet's

More news about: SOLIGENIX, INC.


Oct 06, 2025, 08:45 ET Nutex Health Inc. Securities Fraud Class Action Lawsuit Pending: Contact The Gross Law Firm Before October 21, 2025 to Discuss Your Rights - NUTX

third-party IDR vendor, was achieving lucrative arbitration results for Nutex by engaging in a coordinated scheme to defraud insurance companies; (ii) as a result, to the extent that they were the product of fraudulent conduct, revenues attributable to the Company's engagement with HaloMD in the IDR process

More news about: Levi & Korsinsky, LLP


Oct 03, 2025, 17:06 ET NUTX Deadline: NUTX Investors Have Opportunity to Lead Nutex Health Inc. Securities Fraud Lawsuit

resolution vendor ("IDR"), was achieving lucrative arbitration results for Nutex by engaging in a coordinated scheme to defraud insurance companies; (2) as a result, to the extent that they were the product of fraudulent conduct, revenues attributable to Nutex's engagement with HaloMD in the IDR process were

More news about: THE ROSEN LAW FIRM, P. A.


Oct 03, 2025, 10:40 ET SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Nutex Health

(2) as a result, to the extent that they were the product of fraudulent conduct, revenues attributable to the Company's engagement with HaloMD in the IDR process were unsustainable; (3) in addition, the Company overstated the extent to which it had remediated, and/or its ability to remediate, the material

More news about: Faruqi & Faruqi, LLP


Oct 03, 2025, 10:00 ET Pomerantz Law Firm Announces the Filing of a Class Action Against Nutex Health Inc. and Certain Officers - NUTX

appeals using the IDR process."  In response, in July 2024, the Company engaged with HaloMD, a "third-party IDR vendor," to "assist in the recovery of certain out of network claims" in the IDR process.  While Nutex did not disclose the identity of its third-party IDR vendor to investors

More news about: Pomerantz LLP


Oct 02, 2025, 17:25 ET Nutex Health Inc. (NUTX) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit

(2) as a result, to the extent that they were the product of fraudulent conduct, revenues attributable to the Company's engagement with HaloMD in the IDR process were unsustainable; (3) in addition, the Company overstated the extent to which it had remediated, and/or its ability to remediate, the material

More news about: The Law Offices of Frank R. Cruz, Los Angeles


Oct 01, 2025, 08:45 ET Lost Money on Nutex Health Inc.(NUTX)? Join Class Action Suit Seeking Recovery - Contact Levi & Korsinsky

third-party IDR vendor, was achieving lucrative arbitration results for Nutex by engaging in a coordinated scheme to defraud insurance companies; (ii) as a result, to the extent that they were the product of fraudulent conduct, revenues attributable to the Company's engagement with HaloMD in the IDR process

More news about: Levi & Korsinsky, LLP


Sep 30, 2025, 12:00 ET Nutex Health Inc. (NUTX) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit

(2) as a result, to the extent that they were the product of fraudulent conduct, revenues attributable to the Company's engagement with HaloMD in the IDR process were unsustainable; (3) in addition, the Company overstated the extent to which it had remediated, and/or its ability to remediate, the material

More news about: Law Offices of Howard G. Smith


Sep 30, 2025, 07:30 ET Soligenix Announces Expansion of European Medical Advisory Board for Cutaneous T-Cell Lymphoma

programs in this business segment also include expansion of synthetic hypericin (SGX302) into psoriasis, our first-in-class innate defense regulator (IDR) technology, dusquetide (SGX942) for the treatment of inflammatory diseases, including oral mucositis in head and neck cancer, and (SGX945) in Behçet's

More news about: SOLIGENIX, INC.


Sep 29, 2025, 16:05 ET Soligenix Announces Closing of $7.5 Million Public Offering

this business segment also include expansion of synthetic hypericin (SGX302) into psoriasis, the Company's first-in-class innate defense regulator (IDR) technology, dusquetide (SGX942) for the treatment of inflammatory diseases, including oral mucositis in head and neck cancer, and (SGX945) in Behçet's

More news about: SOLIGENIX, INC.


Sep 29, 2025, 15:03 ET NUTX Investors Have Opportunity to Lead Nutex Health Inc. Securities Fraud Lawsuit

resolution vendor ("IDR"), was achieving lucrative arbitration results for Nutex by engaging in a coordinated scheme to defraud insurance companies; (2) as a result, to the extent that they were the product of fraudulent conduct, revenues attributable to Nutex's engagement with HaloMD in the IDR process were

More news about: THE ROSEN LAW FIRM, P. A.


Sep 29, 2025, 08:45 ET Class Action Filed Against Nutex Health Inc. (NUTX) Seeking Recovery for Investors - Contact The Gross Law Firm

third-party IDR vendor, was achieving lucrative arbitration results for Nutex by engaging in a coordinated scheme to defraud insurance companies; (ii) as a result, to the extent that they were the product of fraudulent conduct, revenues attributable to the Company's engagement with HaloMD in the IDR process

More news about: The Gross Law Firm


Sep 28, 2025, 10:00 ET Pomerantz Law Firm Announces the Filing of a Class Action Against Nutex Health Inc. and Certain Officers - NUTX

appeals using the IDR process."  In response, in July 2024, the Company engaged with HaloMD, a "third-party IDR vendor," to "assist in the recovery of certain out of network claims" in the IDR process. While Nutex did not disclose the identity of its third-party IDR vendor to investors

More news about: Pomerantz LLP


Making a selection with these dropdown will cause content on this page to change. News search result will update as each option is selected.